It acts pro-angiogenically via VEGFR2: the peptide promotes VEGFR2 internalization and activates the VEGFR2-Akt-eNOS pathway, which is blocked by the endocytosis inhibitor Dynasore, and in preclinical models it increased vessel density as well as the restoration of blood flow in the ischemic rat hindlimb Hsieh et al., 2017
Janet Woodcock, a retired FDA veteran and former principal deputy commissioner
Dual/triple peptides for the treatment of obesity and diabetes Dual glucagon/GLP-1 receptor co-agonists The use of glucagon in patients with type 2 diabetes might seem illogical because of its action of promoting hyperglycaemia
Ann NY Acad Sci 1321:119 Wu G, Cross HR, Gehring KB et al (2016) Composition of free and peptide-bound amino acids in beef chuck, loin, and round cuts
The gastric emptying effect Semaglutide is a GLP-1 receptor agonist, meaning it mimics the incretin hormone GLP-1 that the body naturally produces after eating